EBITDA Summary of Fujian Cosunter Pharmaceutical Co., Ltd.

Fujian Cosunter Pharmaceutical Co., Ltd.'s latest annual EBITDA in 2023 was -190.85 Million CNY , down -104.78% from previous year.
Fujian Cosunter Pharmaceutical Co., Ltd.'s latest quarterly EBITDA in 2024 Q3 was -26.89 Million CNY , down -137.52% from previous quarter.
Fujian Cosunter Pharmaceutical Co., Ltd. reported an annual EBITDA of -94.23 Million CNY in 2022, down -586.14% from previous year.
Fujian Cosunter Pharmaceutical Co., Ltd. reported an annual EBITDA of 15.41 Million CNY in 2021, down -71.38% from previous year.
Fujian Cosunter Pharmaceutical Co., Ltd. reported a quarterly EBITDA of -26.89 Million CNY for 2024 Q3, down -137.52% from previous quarter.
Fujian Cosunter Pharmaceutical Co., Ltd. reported a quarterly EBITDA of -5.2 Million CNY for 2024 Q1, up 108.12% from previous quarter.

Annual EBITDA Chart of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual EBITDA of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Year	EBITDA	EBITDA Growth
2023	-190.85 Million CNY	-104.78%
2022	-94.23 Million CNY	-586.14%
2021	15.41 Million CNY	-71.38%
2020	49.98 Million CNY	16.42%
2019	53.97 Million CNY	42.25%
2018	40.89 Million CNY	-12.96%
2017	43.71 Million CNY	-42.16%
2016	75.77 Million CNY	-41.43%
2015	130.52 Million CNY	23.58%
2014	105.46 Million CNY	49.73%
2013	70.37 Million CNY	33.57%
2012	52.39 Million CNY	34.9%
2011	39.34 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-9.11 Million CNY	-227.82%
2024 Q3	-26.89 Million CNY	-137.52%
2024 Q1	-5.2 Million CNY	108.12%
2023 Q4	-97.26 Million CNY	-234.6%
2023 Q1	-70.7 Million CNY	-4.15%
2023 Q2	-57.61 Million CNY	18.53%
2023 Q3	-29.06 Million CNY	49.54%
2023 FY	- CNY	-104.78%
2022 Q3	-48.66 Million CNY	-121.6%
2022 Q2	-21.96 Million CNY	-138.62%
2022 Q1	-9.2 Million CNY	38.26%
2022 Q4	-67.89 Million CNY	-39.51%
2022 FY	- CNY	-586.14%
2021 Q2	-19.21 Million CNY	-646.19%
2021 Q4	-14.9 Million CNY	-389.28%
2021 Q3	-3.04 Million CNY	84.14%
2021 FY	- CNY	-71.38%
2021 Q1	3.51 Million CNY	28.12%
2020 Q4	2.74 Million CNY	-61.55%
2020 FY	- CNY	16.42%
2020 Q1	4.71 Million CNY	269.44%
2020 Q3	7.14 Million CNY	-41.23%
2020 Q2	12.15 Million CNY	157.8%
2019 Q1	11.24 Million CNY	41.15%
2019 Q4	-2.78 Million CNY	-137.74%
2019 FY	- CNY	42.25%
2019 Q3	7.37 Million CNY	59.4%
2019 Q2	4.62 Million CNY	-58.87%
2018 Q2	-8.73 Million CNY	-164.85%
2018 Q1	13.46 Million CNY	11682.76%
2018 Q4	7.96 Million CNY	160.08%
2018 FY	- CNY	-12.96%
2018 Q3	3.06 Million CNY	135.07%
2017 Q4	114.28 Thousand CNY	127.22%
2017 Q1	23.61 Million CNY	1545.62%
2017 FY	- CNY	-42.16%
2017 Q2	5.9 Million CNY	-75.0%
2017 Q3	-419.89 Thousand CNY	-107.11%
2016 Q4	1.43 Million CNY	-93.12%
2016 FY	- CNY	-41.43%
2016 Q3	20.85 Million CNY	78.8%
2016 Q2	11.66 Million CNY	-62.59%
2016 Q1	31.17 Million CNY	-0.72%
2015 Q4	31.4 Million CNY	-5.66%
2015 FY	- CNY	23.58%
2015 Q3	33.28 Million CNY	6.7%
2015 Q2	31.19 Million CNY	-2.02%
2015 Q1	31.83 Million CNY	27.01%
2014 Q2	23.12 Million CNY	3.43%
2014 Q1	22.35 Million CNY	0.0%
2014 FY	- CNY	49.73%
2014 Q4	25.06 Million CNY	-12.61%
2014 Q3	28.68 Million CNY	24.06%
2013 FY	- CNY	33.57%
2012 FY	- CNY	34.9%
2011 FY	- CNY	0.0%

Peer EBITDA Comparison of Fujian Cosunter Pharmaceutical Co., Ltd.

Name	EBITDA	EBITDA Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	-141.51 Million CNY	-34.871%
Anhui Fengyuan Pharmaceutical Co., Ltd.	388.66 Million CNY	149.106%
Dong-E-E-Jiao Co.,Ltd.	1.53 Billion CNY	112.398%
Livzon Pharmaceutical Group Inc.	3.29 Billion CNY	105.788%
Hainan Haiyao Co., Ltd.	152.19 Million CNY	225.403%
Tus-Pharmaceutical Group Co., Ltd.	62.18 Million CNY	406.931%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.87 Billion CNY	110.161%
Changchun High-Tech Industries (Group) Inc.	6.09 Billion CNY	103.131%
Apeloa Pharmaceutical Co.,Ltd	1.79 Billion CNY	110.651%
PKU HealthCare Corp.,Ltd.	132.39 Million CNY	244.162%
Chengdu Huasun Technology Group Inc., Ltd.	74.04 Million CNY	357.761%
Dezhan Healthcare Company Limited	219.36 Million CNY	187.007%
Jinling Pharmaceutical Company Limited	249.63 Million CNY	176.457%
Jiuzhitang Co., Ltd.	460.28 Million CNY	141.465%
Huapont Life Sciences Co., Ltd.	2.12 Billion CNY	108.972%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	945.42 Million CNY	120.188%
Shandong Wohua Pharmaceutical Co., Ltd.	87.98 Million CNY	316.91%
Hengkang Medical Group Co., Ltd.	348.09 Million CNY	154.829%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	453.78 Million CNY	142.059%
Qianjiang Yongan Pharmaceutical Co., Ltd.	141.6 Million CNY	234.779%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	124.71 Million CNY	253.03%
Jinhe Biotechnology CO., LTD.	345.42 Million CNY	155.254%
Teyi Pharmaceutical Group Co.,Ltd	369.46 Million CNY	151.658%
Kunming Longjin Pharmaceutical Co., Ltd.	-31.19 Million CNY	-511.771%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-112.74 Million CNY	-69.282%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.38 Billion CNY	113.744%
Anhui Huangshan Capsule Co., Ltd.	118.18 Million CNY	261.488%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	166.4 Million CNY	214.693%
Zhuhai Rundu Pharmaceutical Co., Ltd.	215.02 Million CNY	188.762%
Huaren Pharmaceutical Co., Ltd.	431.65 Million CNY	144.216%
Tianjin Ringpu Bio-Technology Co.,Ltd.	711.43 Million CNY	126.827%
Shanxi Zhendong Pharmaceutical Co.,Ltd	94.75 Million CNY	301.426%
Fuan Pharmaceutical (Group) Co., Ltd.	528.99 Million CNY	136.08%
Hybio Pharmaceutical Co., Ltd.	-233.61 Million CNY	18.302%
Baotou Dongbao Bio-Tech Co.,Ltd	236.24 Million CNY	180.789%
Hunan Er-Kang Pharmaceutical Co., Ltd	12.02 Million CNY	1687.519%
Changjiang Pharmaceutical Group Co., Ltd.	-572.69 Million CNY	66.674%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	383.11 Million CNY	149.817%
Beijing Science Sun Pharmaceutical Co., Ltd.	7.7 Million CNY	2577.708%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	87.94 Million CNY	317.008%
Hainan Poly Pharm. Co., Ltd	309.33 Million CNY	161.699%
Jiangxi Synergy Pharmaceutical Co., Ltd.	192.54 Million CNY	199.126%
Wuhan Hiteck Biological Pharma Co.,Ltd	-73.65 Million CNY	-159.117%
Shandong Xinhua Pharmaceutical Company Limited	1.09 Billion CNY	117.421%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	435.22 Million CNY	143.853%
PharmaBlock Sciences (Nanjing), Inc.	380.8 Million CNY	150.12%
Jinghua Pharmaceutical Group Co., Ltd.	417.61 Million CNY	145.703%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-43.99 Million CNY	-333.829%
Betta Pharmaceuticals Co., Ltd.	696.09 Million CNY	127.419%
Tibet AIM Pharm. Inc.	50.76 Million CNY	475.988%
Shenzhen Kangtai Biological Products Co., Ltd.	1.29 Billion CNY	114.737%
Shandong Shanda Wit Science and Technology Co., Ltd.	1.39 Billion CNY	113.643%
Pacific Shuanglin Bio-pharmacy Co., LTD	841.98 Million CNY	122.668%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	300.14 Million CNY	163.589%
Xiamen Kingdomway Group Company	588.78 Million CNY	132.416%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	127.06 Million CNY	250.206%
Walvax Biotechnology Co., Ltd.	938.22 Million CNY	120.342%
Sunflower Pharmaceutical Group Co.,Ltd	1.54 Billion CNY	112.338%
Harbin Gloria Pharmaceuticals Co., Ltd	275.28 Million CNY	169.331%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	4.68 Billion CNY	104.071%
Hunan Hansen Pharmaceutical Co., Ltd.	280.66 Million CNY	168.003%
Changzhou Qianhong Biopharma CO.,LTD	278.66 Million CNY	168.49%
Shenzhen Weiguang Biological Products Co., Ltd.	350.21 Million CNY	154.498%
Honz Pharmaceutical Co., Ltd.	133.53 Million CNY	242.93%
Northeast Pharmaceutical Group Co., Ltd.	1.19 Billion CNY	115.952%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	217.47 Million CNY	187.761%
Guizhou Xinbang Pharmaceutical Co., Ltd.	654.01 Million CNY	129.183%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	477.37 Million CNY	139.981%
Zhejiang Yatai Pharmaceutical Co., Ltd.	76.31 Million CNY	350.099%
Zhejiang NHU Company Ltd.	5.24 Billion CNY	103.637%
ApicHope Pharmaceutical Co., Ltd	464.04 Million CNY	141.13%
Shanghai Kaibao Pharmaceutical CO.,Ltd	375.33 Million CNY	150.85%
Beijing SL Pharmaceutical Co., Ltd.	610.29 Million CNY	131.273%
Yunnan Baiyao Group Co.,Ltd	5.2 Billion CNY	103.665%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	127.72 Million CNY	249.435%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	228.9 Million CNY	183.381%
Guangdong Lifestrong Pharmacy Co., Ltd.	50.95 Million CNY	474.528%
Huadong Medicine Co., Ltd	4.61 Billion CNY	104.134%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.33 Billion CNY	114.253%
Harbin Medisan Pharmaceutical Co., Ltd.	183.66 Million CNY	203.918%
LanZhou Foci Pharmaceutical Co.,Ltd.	135.36 Million CNY	240.992%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	1.04 Billion CNY	118.229%
Beijing Beilu Pharmaceutical Co., Ltd	36.44 Million CNY	623.682%
Nanjing Hicin Pharmaceutical Co., Ltd.	97 Million CNY	296.759%
Renhe Pharmacy Co., Ltd.	1.05 Billion CNY	118.166%
Chongqing Pharscin Pharmaceutical Co., Ltd.	125.84 Million CNY	251.658%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	863.95 Million CNY	122.091%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-320.08 Million CNY	40.373%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-298.6 Million CNY	36.084%

Global Stocks Search

Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ)

EBITDA Summary of Fujian Cosunter Pharmaceutical Co., Ltd.

Annual EBITDA Chart of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual EBITDA of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Peer EBITDA Comparison of Fujian Cosunter Pharmaceutical Co., Ltd.